These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24033779)

  • 1. Commentary on Subbaraman et al. (2013) [corrected]: cravings as a mediator and moderator of drinking outcomes in the COMBINE Study.
    Anton RF
    Addiction; 2013 Oct; 108(10):1745-6. PubMed ID: 24033779
    [No Abstract]   [Full Text] [Related]  

  • 2. Cravings as a mediator and moderator of drinking outcomes in the COMBINE study.
    Subbaraman MS; Lendle S; van der Laan M; Kaskutas LA; Ahern J
    Addiction; 2013 Oct; 108(10):1737-44. PubMed ID: 23668624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.
    Fucito LM; Park A; Gulliver SB; Mattson ME; Gueorguieva RV; O'Malley SS
    Biol Psychiatry; 2012 Nov; 72(10):832-8. PubMed ID: 22541040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study.
    Gueorguieva R; Wu R; Donovan D; Rounsaville BJ; Couper D; Krystal JH; O'Malley SS
    Drug Alcohol Depend; 2010 Mar; 107(2-3):221-9. PubMed ID: 19969427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone improves outcome of a controlled drinking program.
    Rubio G; Manzanares J; Lopez-Muñoz F; Alamo C; Ponce G; Jimenez-Arriero MA; Palomo T
    J Subst Abuse Treat; 2002 Dec; 23(4):361-6. PubMed ID: 12495798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing pharmacotherapies for the COMBINE Study--process and procedures: an investigational approach to combination pharmacotherapy for the treatment of alcohol dependence.
    Swift R; Pettinati HM
    J Stud Alcohol Suppl; 2005 Jul; (15):141-7; discussion 140. PubMed ID: 16223065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
    Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes.
    Mann K; Roos CR; Hoffmann S; Nakovics H; Leménager T; Heinz A; Witkiewitz K
    Neuropsychopharmacology; 2018 Mar; 43(4):891-899. PubMed ID: 29154368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.
    Gueorguieva R; Wu R; Donovan D; Rounsaville BJ; Couper D; Krystal JH; O'Malley SS
    Alcohol Clin Exp Res; 2011 Mar; 35(3):523-31. PubMed ID: 21143249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Ralevski E; Rounsaville B
    Biol Psychiatry; 2006 Oct; 60(7):777-83. PubMed ID: 17008146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological features of naltrexone and its use in the treatment of alcohol dependence].
    Bieńkowski P
    Psychiatr Pol; 2013; 47(1):117-26. PubMed ID: 23888749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care.
    Ernst DB; Pettinati HM; Weiss RD; Donovan DM; Longabaugh R
    Ann Fam Med; 2008; 6(5):435-40. PubMed ID: 18779548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of naltrexone in the management of alcohol dependence.
    Garbutt JC
    Curr Pharm Des; 2010; 16(19):2091-7. PubMed ID: 20482515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on Murphy et al.: What will it take to prescribe extended-release naltrexone to treat alcohol use disorder?
    Springer SA
    Addiction; 2022 Feb; 117(2):282-283. PubMed ID: 34549844
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between a brief alcohol craving measure and drinking in the following week.
    McHugh RK; Fitzmaurice GM; Griffin ML; Anton RF; Weiss RD
    Addiction; 2016 Jun; 111(6):1004-10. PubMed ID: 26780476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous Abstinence During Early Alcohol Treatment is Significantly Associated with Positive Treatment Outcomes, Independent of Duration of Abstinence.
    Dunn KE; Harrison JA; Leoutsakos JM; Han D; Strain EC
    Alcohol Alcohol; 2017 Jan; 52(1):72-79. PubMed ID: 27567268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of extended release naltrexone to reduce alcohol cravings and use behaviors during treatment and at follow-up.
    Crèvecoeur-MacPhail D; Cousins SJ; Denering L; Kim T; Rawson RA
    J Subst Abuse Treat; 2018 Feb; 85():105-108. PubMed ID: 29174308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.